Latest News

The NMPA based its decision on compelling evidence from the TRIDENT-1 study, a pivotal Phase I/II clinical trial that demonstrated the drug’s effectiveness over time.

This acquisition expands Fullerton Health’s network of high-quality specialist care throughout Southeast Asia.

Doctors discovered that Khan’s sudden vision loss stemmed from a large arachnoid cyst in his brain, which created dangerously high pressure inside his skull and compressed the areas responsible for sight.

Environmental sustainability stands as a cornerstone of the 2024 report, with the company achieving a 58% reduction in diesel consumption and a 64% decrease in refrigerant gas usage.

The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.

This strategic shift addresses mounting concerns about regulatory compliance and workforce development in the country’s healthcare sector.

The Pharmacy and Poisons Board has approved both the 300 mg tablet and 464 mg injectable solution forms of Lenacapavir for use as pre-exposure prophylaxis (PrEP).

The sale came about following an unsolicited offer from BGH Capital, which focuses on investments in Australia and New Zealand.

This cutting-edge approach represents a major advancement in how doctors can treat genetic diseases by directly modifying the faulty genes responsible for these conditions.

The deal collapsed after STAAR failed to secure sufficient shareholder approval during a special stockholders meeting held on January 6.